August 2021 in “Pharmacy Today” This article discusses nonprescription treatments for hereditary pattern hair loss, highlighting minoxidil's role and guidelines for use, but reports no new clinical results.
June 2021 in “International Journal of Research in Medical Sciences & Technology” This article reviews various causes and treatments for alopecia, including nutritional deficiencies, stress, and hormonal changes, and reports no new clinical results.
June 2021 in “Elsevier eBooks” This chapter reviews diffuse hair loss conditions like androgenetic alopecia, lichen planopilaris, telogen effluvium, and alopecia areata, but it provides no new clinical findings.
2 citations
,
November 2018 in “Seminars in Cutaneous Medicine and Surgery” This source reviews treatments for female pattern hair loss and discusses the challenges in achieving effective regrowth, highlighting the need for combinations of topical, systemic, and interventional therapies.
This article discusses various causes and prevention methods for male pattern baldness but reports no new research findings.
August 2013 in “Pharmacy Today” In a recent study of 15 women with self-perceived hair loss, Viviscal supplementation was associated with an increase in terminal hairs and subjective improvement in hair characteristics.
54 citations
,
September 2012 in “Dermatologic Clinics” This review discusses possible medication-induced hair loss and the need to exclude other confounding factors like stress and illness; it reports no new clinical findings and emphasizes careful assessment before attributing hair loss to medications.
10 citations
,
July 2007 in “PubMed” This study on 8 cancer patients receiving chemotherapy found that both anagen and telogen effluvium may contribute to diffuse moderate alopecia within a month of treatment onset.
